Literature DB >> 17329442

Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay.

Mette A Strid1, Tine Dalby, Kåre Mølbak, Karen A Krogfelt.   

Abstract

Two indirect enzyme-linked immunosorbent assays (ELISAs) were employed to measure levels of immunoglobulin G (IgG), IgM, and IgA antibodies against Salmonella in sera from 303 Danish patients diagnosed by fecal culture with either Salmonella enterica serovar Enteritidis or Salmonella enterica serovar Typhimurium infections. The ELISAs were based on serovar Enteritidis lipopolysaccharide (LPS) and serovar Typhimurium LPS. The antibody levels were assessed approximately 1, 3, 6, and 12 months after the onset of salmonellosis. Sera from 164 healthy blood donors were analyzed to establish cutoff values for each analysis. One month after the onset of symptoms, the sensitivities of the assays were 95% for patients recovering from a serovar Enteritidis infection and 89% for patients recovering from a serovar Typhimurium infection. Three months after the onset of symptoms, these values had decreased to 85% and 55%. At 6 months they were 62% and 40%, and at 12 months they were 40% and 16%, respectively. The specificities of the assays were 97% for the serovar Enteritidis LPS ELISA and 94% for the serovar Typhimurium LPS ELISA. The high values for both sensitivity and specificity make these two ELISAs useful for serodiagnoses of Salmonella infection shortly after the acute phase of the infection and of Salmonella-associated reactive arthritis, as well as for seroepidemiological studies. A mixed ELISA consisting of both antigens, i.e., serovar Enteritidis and serovar Typhimurium LPS, was developed as a diagnostic tool with very high values for both specificity and sensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329442      PMCID: PMC1951089          DOI: 10.1128/CVI.00192-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  9 in total

Review 1.  Animal models of Salmonella infections: enteritis versus typhoid fever.

Authors:  R L Santos; S Zhang; R M Tsolis; R A Kingsley; L G Adams; A J Bäumler
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

2.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  Rapid decay of Salmonella flagella antibodies during human gastroenteritis: a follow up study.

Authors:  Tine Dalby; Mette A Strid; Natascha H Beyer; Jens Blom; Kåre Mølbak; Karen A Krogfelt
Journal:  J Microbiol Methods       Date:  2005-03-19       Impact factor: 2.363

4.  High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis.

Authors:  Henning Locht; Kåre Mølbak; Karen A Krogfelt
Journal:  J Rheumatol       Date:  2002-04       Impact factor: 4.666

5.  Serological diagnosis of salmonella infections by enzyme immunoassay.

Authors:  O Isomäki; R Vuento; K Granfors
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

Review 6.  Nontyphoidal salmonellosis.

Authors:  E L Hohmann
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

7.  Quantitation of Salmonella O-antibodies in human sera by enzyme-linked immunosorbent assay (ELISA).

Authors:  H E Carlsson; A A Lindberg; S Hammarström; A Ljunggren
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

8.  Secretory immune response and clinical sequelae of Salmonella infection in a point source cohort.

Authors:  G T Thomson; M Alfa; K Orr; B R Thomson; N Olson
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

9.  Diagnosis of Salmonella infections: specificity of indirect immunofluorescence for rapid identification of Salmonella enteritidis and usefulness of enzyme-linked immunosorbent assay.

Authors:  B Svenungsson; H Jörbeck; A A Lindberg
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

  9 in total
  14 in total

1.  Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans.

Authors:  J Simonsen; M A Strid; K Mølbak; K A Krogfelt; A Linneberg; P Teunis
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

2.  Role of Salmonella enterica exposure in Chilean Crohn's disease patients.

Authors:  Manuel Alvarez-Lobos; Daniela P Pizarro; Christian E Palavecino; Abner Espinoza; Valentina P Sebastián; Juan C Alvarado; Patricio Ibañez; Carlos Quintana; Orlando Díaz; Alexis M Kalergis; Susan M Bueno
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Diagnostics for invasive Salmonella infections: Current challenges and future directions.

Authors:  Jason R Andrews; Edward T Ryan
Journal:  Vaccine       Date:  2015-04-30       Impact factor: 3.641

4.  Inhibition of intestinal ascorbic acid uptake by lipopolysaccharide is mediated via transcriptional mechanisms.

Authors:  Veedamali S Subramanian; Subrata Sabui; Hamid Moradi; Jonathan S Marchant; Hamid M Said
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-10-10       Impact factor: 3.747

5.  Lipopolysaccharide inhibits colonic biotin uptake via interference with membrane expression of its transporter: a role for a casein kinase 2-mediated pathway.

Authors:  Ram Lakhan; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-04       Impact factor: 4.249

6.  Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases.

Authors:  Gerhard Falkenhorst; Jacob Simonsen; Tina H Ceper; Wilfrid van Pelt; Henriette de Valk; Malgorzata Sadkowska-Todys; Lavinia Zota; Markku Kuusi; Cecilia Jernberg; Maria Cristina Rota; Yvonne Thp van Duynhoven; Peter Fm Teunis; Karen A Krogfelt; Kåre Mølbak
Journal:  BMC Public Health       Date:  2012-07-16       Impact factor: 3.295

7.  Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels.

Authors:  Benjamin F Arnold; Mark J van der Laan; Alan E Hubbard; Cathy Steel; Joseph Kubofcik; Katy L Hamlin; Delynn M Moss; Thomas B Nutman; Jeffrey W Priest; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2017-05-19

8.  Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.

Authors:  Tine Dalby; Eva Rasmussen; Peter Schiellerup; Karen Angeliki Krogfelt
Journal:  BMC Microbiol       Date:  2017-05-25       Impact factor: 3.605

9.  Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children.

Authors:  Jiin Felgner; Aarti Jain; Rie Nakajima; Li Liang; Algis Jasinskas; Eduardo Gotuzzo; Joseph M Vinetz; Fabio Miyajima; Munir Pirmohamed; Fatimah Hassan-Hanga; Dominic Umoru; Binta Wudil Jibir; Safiya Gambo; Kudirat Olateju; Philip L Felgner; Stephen Obaro; D Huw Davies
Journal:  PLoS Negl Trop Dis       Date:  2017-06-22

10.  Production of recombinant flagellin to develop ELISA-based detection of Salmonella Enteritidis.

Authors:  Seyed Ali Mirhosseini; Abbas Ali Imani Fooladi; Jafar Amani; Hamid Sedighian
Journal:  Braz J Microbiol       Date:  2017-07-07       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.